What is Roth Capital’s Estimate for TENX FY2024 Earnings?
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Equities researchers at Roth Capital reduced their FY2024 earnings per share estimates for shares of Tenax Therapeutics in a note issued to investors on Wednesday, March 5th. Roth Capital analyst J. Aschoff now expects that the specialty pharmaceutical company will post earnings of ($1.20) per share for […]
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Equities researchers at Roth Capital reduced their FY2024 earnings per share estimates for shares of Tenax Therapeutics in a note issued to investors on Wednesday, March 5th. Roth Capital analyst J. Aschoff now expects that the specialty pharmaceutical company will post earnings of ($1.20) per share for […]
